XML 79 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries (Tables)
12 Months Ended
Dec. 31, 2018
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries [Abstract]  
Supplemental Condensed Consolidating Balance Sheet
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2018
 
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
73.5

 
$
0.9

 
$

 
$
95.1

 
$
(1.3
)
 
$
168.2

Restricted cash
 

 
0.8

 
31.6

 
6.3

 

 
38.7

Accounts receivable, net
 

 
79.2

 
204.8

 
315.2

 

 
599.2

Notes receivable, net
 

 

 
100.6

 
13.3

 

 
113.9

Inventories
 

 
40.4

 
81.7

 
110.8

 
(17.3
)
 
215.6

Prepaid expenses, deposits and other current assets
 
6.2

 
63.3

 
92.5

 
70.5

 
0.2

 
232.7

Property and equipment, net
 
31.0

 
112.1

 
218.6

 
218.2

 
(32.9
)
 
547.0

Investment in subsidiaries
 
2,835.9

 
974.5

 
1,093.4

 

 
(4,903.8
)
 

Goodwill
 

 
240.2

 
1,896.8

 
1,142.9

 

 
3,279.9

Intangible assets, net
 
42.6

 
34.1

 
1,291.4

 
441.0

 

 
1,809.1

Intercompany balances
 

 
6,053.9

 

 

 
(6,053.9
)
 

Software, net
 
58.6

 
38.2

 
128.3

 
60.2

 

 
285.3

Other assets(2)
 
110.0

 
404.4

 
45.9

 
307.8

 
(439.9
)
 
428.2

Total assets
 
$
3,157.8

 
$
8,042.0

 
$
5,185.6

 
$
2,781.3

 
$
(11,448.9
)
 
$
7,717.8

Liabilities and stockholders’ (deficit) equity
 


 


 


 


 


 
 
Current portion of long-term debt
 
$

 
$
41.7

 
$

 
$
3.3

 
$

 
$
45.0

Other current liabilities
 
63.8

 
162.4

 
247.9

 
254.1

 
(25.9
)
 
702.3

Long-term debt, excluding current portion
 

 
8,991.1

 

 
0.8

 

 
8,991.9

Other long-term liabilities
 
105.8

 
7.6

 
637.3

 
171.9

 
(480.8
)
 
441.8

Intercompany balances
 
5,451.4

 

 
48.1

 
554.4

 
(6,053.9
)
 

Stockholders’ (deficit) equity
 
(2,463.2
)
 
(1,160.8
)
 
4,252.3

 
1,796.8

 
(4,888.3
)
 
(2,463.2
)
Total liabilities and stockholders’ (deficit) equity
 
$
3,157.8

 
$
8,042.0

 
$
5,185.6

 
$
2,781.3

 
$
(11,448.9
)
 
$
7,717.8

 
1 - Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
2 - Includes $12.2 million and $0.9 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.

SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET
As of December 31, 2017
 
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Assets
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
732.6

 
$

 
$

 
$
59.4

 
$
(3.2
)
 
$
788.8

Restricted cash
 

 
0.6

 
28.3

 
0.1

 

 
29.0

Accounts receivable, net
 
0.4

 
68.1

 
192.6

 
279.8

 

 
540.9

Notes receivable, net
 

 

 
121.1

 
22.4

 

 
143.5

Inventories
 

 
40.7

 
91.8

 
131.8

 
(21.2
)
 
243.1

Prepaid expenses, deposits and other current assets
 
6.5

 
30.3

 
41.6

 
52.7

 

 
131.1

Property and equipment, net
 
28.8

 
91.5

 
295.6

 
179.9

 
(27.6
)
 
568.2

Investment in subsidiaries
 
3,098.7

 
867.9

 
987.7

 

 
(4,954.3
)
 

Goodwill
 

 
240.3

 
1,880.4

 
835.4

 

 
2,956.1

Intangible assets, net
 
15.7

 
34.9

 
1,335.3

 
218.7

 

 
1,604.6

Intercompany balances
 

 
5,889.8

 

 
222.5

 
(6,112.3
)
 

Software, net
 
67.2

 
24.7

 
199.0

 
48.5

 

 
339.4

Other assets(2)
 
234.4

 
388.8

 
62.0

 
270.3

 
(574.9
)
 
380.6

Total assets
 
$
4,184.3

 
$
7,677.6

 
$
5,235.4

 
$
2,321.5

 
$
(11,693.5
)
 
$
7,725.3

Liabilities and stockholders’ (deficit) equity
 
 

 
 

 
 

 
 

 
 

 


Current portion of long-term debt
 
$

 
$
32.8

 
$

 
$
7.5

 
$

 
$
40.3

Other current liabilities
 
67.6

 
199.0

 
254.2

 
206.4

 
(27.7
)
 
699.5

Long-term debt, excluding current portion
 

 
8,733.0

 

 
3.3

 

 
8,736.3

Other long-term liabilities
 
68.8

 
11.3

 
650.3

 
110.9

 
(565.1
)
 
276.2

Intercompany balances
 
6,074.9

 

 
37.4

 

 
(6,112.3
)
 

Stockholders’ (deficit) equity
 
(2,027.0
)
 
(1,298.5
)
 
4,293.5

 
1,993.4

 
(4,988.4
)
 
(2,027.0
)
Total liabilities and stockholders’ (deficit) equity
 
$
4,184.3

 
$
7,677.6

 
$
5,235.4

 
$
2,321.5

 
$
(11,693.5
)
 
$
7,725.3

 
 
 
 
 
 
 
 
 
 
 
 
 
1 - Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, the 2025 Secured Notes and the Unsecured Notes.
2 - Includes $15.6 million and $0.7 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
Supplemental Condensed Consolidating Statement of Operations and Comprehensive Loss
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF
OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
Year Ended December 31, 2018
 
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Revenue
 
$

 
$
547.1

 
$
1,654.0

 
$
1,540.3

 
$
(378.2
)
 
$
3,363.2

Cost of services, cost of product sales and cost of instant products(2)
 

 
360.9

 
490.3

 
721.2

 
(317.1
)
 
1,255.3

Selling, general and administrative
 
154.4

 
42.4

 
227.0

 
325.5

 
(52.4
)
 
696.9

Research and development
 

 
2.7

 
87.2

 
112.4

 

 
202.3

Depreciation, amortization and impairments
 
44.2

 
32.6

 
439.4

 
188.3

 
(14.8
)
 
689.7

Restructuring and other
 
194.7

 
(1.1
)
 
9.2

 
50.6

 

 
253.4

Operating (loss) income
 
(393.3
)
 
109.6

 
400.9

 
142.3

 
6.1

 
265.6

Interest expense
 

 
(596.7
)
 

 
(0.5
)
 

 
(597.2
)
Loss on debt financing transactions
 

 
(93.2
)
 

 

 

 
(93.2
)
Gain on remeasurement of debt
 

 
43.4

 

 

 

 
43.4

Other income (expense), net
 
335.7

 
534.9

 
(744.8
)
 
(83.7
)
 

 
42.1

Net (loss) income before equity in (loss) income of subsidiaries and income taxes
 
(57.6
)
 
(2.0
)
 
(343.9
)
 
58.1

 
6.1

 
(339.3
)
Equity in (loss) income of subsidiaries
 
(218.5
)
 
43.6

 
(28.2
)
 

 
203.1

 

Income tax (expense) benefit
 
(76.3
)
 
0.5

 
82.3

 
(19.6
)
 

 
(13.1
)
Net (loss) income
 
$
(352.4
)
 
$
42.1

 
$
(289.8
)
 
$
38.5

 
$
209.2

 
$
(352.4
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive (loss) income
 
(99.8
)
 
30.0

 
(66.3
)
 
(113.8
)
 
150.1

 
(99.8
)
Comprehensive (loss) income
 
$
(452.2
)
 
$
72.1

 
$
(356.1
)
 
$
(75.3
)
 
$
359.3

 
$
(452.2
)
 
1 - Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.
2 - Exclusive of D&A.

SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF
OPERATIONS AND COMPREHENSIVE LOSS
Year Ended December 31, 2017

 
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Revenue
 
$

 
$
498.1

 
$
1,683.9

 
$
1,223.3

 
$
(321.7
)
 
$
3,083.6

Cost of services, cost of product sales and cost of instant products(2)
 

 
341.9

 
511.0

 
629.1

 
(317.4
)
 
1,164.6

Selling, general and administrative
 
127.1

 
41.3

 
244.4

 
250.2

 
(49.9
)
 
613.1

Research and development
 
2.1

 
6.5

 
101.3

 
74.2

 

 
184.1

Depreciation, amortization and impairments
 
71.6

 
31.3

 
462.7

 
128.0

 
(10.8
)
 
682.8

Restructuring and other
 
29.7

 
5.1

 
7.3

 
3.8

 

 
45.9

Operating (loss) income
 
(230.5
)
 
72.0

 
357.2

 
138.0

 
56.4

 
393.1

Interest expense
 
(4.6
)
 
(603.9
)
 

 
(1.2
)
 

 
(609.7
)
Loss on debt financing transactions
 
(1.1
)
 
(37.0
)
 

 

 

 
(38.1
)
Other income (expense), net
 
87.7

 
150.4

 
(184.7
)
 
(26.5
)
 

 
26.9

Net (loss) income before equity in income of subsidiaries and income taxes
 
(148.5
)
 
(418.5
)
 
172.5

 
110.3

 
56.4

 
(227.8
)
Equity in (loss) income of subsidiaries
 
(45.4
)
 
67.6

 
21.9

 

 
(44.1
)
 

Income tax (expense) benefit
 
(48.4
)
 
157.9

 
(85.6
)
 
(38.4
)
 

 
(14.5
)
Net (loss) income
 
$
(242.3
)
 
$
(193.0
)
 
$
108.8

 
$
71.9

 
$
12.3

 
$
(242.3
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income
 
133.9

 
10.3

 
65.8

 
128.7

 
(204.8
)
 
133.9

Comprehensive (loss) income
 
$
(108.4
)
 
$
(182.7
)
 
$
174.6

 
$
200.6

 
$
(192.5
)
 
$
(108.4
)
 
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes and the 2025 Secured Notes, which were issued in October 2017.
(2) Exclusive of D&A.


SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF
OPERATIONS AND COMPREHENSIVE LOSS
Year Ended December 31, 2016
 
 
SGC (Parent1)
 
SGI (Issuer2)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Revenue
 
$

 
$
469.5

 
$
1,583.5

 
$
1,148.6

 
$
(318.2
)
 
$
2,883.4

Cost of services, cost of product sales and cost of instant products(3)
 

 
328.6

 
480.9

 
553.8

 
(257.0
)
 
1,106.3

Selling, general and administrative
 
121.0

 
46.9

 
213.8

 
235.9

 
(40.6
)
 
577.0

Research and development
 
6.1

 
10.7

 
145.2

 
42.8

 

 
204.8

Depreciation, amortization and impairments
 
53.5

 
40.9

 
534.6

 
116.0

 
(6.3
)
 
738.7

Goodwill impairment
 

 

 

 
69.0

 

 
69.0

Restructuring and other
 
32.6

 
4.6

 
11.7

 
8.1

 

 
57.0

Operating (loss) income
 
(213.2
)
 
37.8

 
197.3

 
123.0

 
(14.3
)
 
130.6

Interest expense
 
(21.0
)
 
(640.2
)
 

 
(0.2
)
 

 
(661.4
)
Gain on debt financing transactions
 

 
25.2

 

 

 

 
25.2

Other income (expense), net
 
64.0

 
194.4

 
(227.3
)
 
(4.2
)
 

 
26.9

Net (loss) income before equity in income of subsidiaries and income taxes
 
(170.2
)
 
(382.8
)
 
(30.0
)
 
118.6

 
(14.3
)
 
(478.7
)
Equity in (loss) income of subsidiaries
 
(180.1
)
 
48.5

 
61.1

 

 
70.5

 

Income tax (expense) benefit
 
(3.4
)
 
138.2

 
15.9

 
(25.7
)
 

 
125.0

Net (loss) income
 
$
(353.7
)
 
$
(196.1
)
 
$
47.0

 
$
92.9

 
$
56.2

 
$
(353.7
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive (loss) income
 
(111.4
)
 
(1.7
)
 
(43.1
)
 
(135.1
)
 
179.9

 
(111.4
)
Comprehensive (loss) income
 
$
(465.1
)
 
$
(197.8
)
 
$
3.9

 
$
(42.2
)
 
$
236.1

 
$
(465.1
)
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Issuer of obligations under the 2018 Notes, which were redeemed on March 17, 2017.
(2) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, and the Unsecured Notes.
(3) Exclusive of D&A.
Supplemental Condensed Consolidating Statement of Cash Flows
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Year Ended December 31, 2018
 
 
SGC (Parent)
 
SGI (Issuer1)
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
 
$
(221.1
)
 
$
18.3

 
$
205.8

 
$
341.2

 
$
1.9

 
$
346.1

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
  Capital expenditures
 
(35.0
)
 
(63.2
)
 
(145.9
)
 
(146.7
)
 

 
(390.8
)
Acquisitions of businesses and assets, net of cash acquired
 

 

 
(32.1
)
 
(264.5
)
 

 
(296.6
)
Proceeds from asset sales
 

 

 
40.0

 

 

 
40.0

Acquisitions and additions to equity method investments
 

 
(1.9
)
 

 
(178.5
)
 

 
(180.4
)
Distributions of capital from equity investments
 

 

 

 
29.7

 

 
29.7

Other, principally change in intercompany investing activities
 

 
(159.3
)
 

 

 
159.3

 

Net cash used in by investing activities
 
(35.0
)
 
(224.4
)
 
(138.0
)
 
(560.0
)
 
159.3

 
(798.1
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Payments on long-term debt, net of proceeds
 

 
245.7

 

 
(7.5
)
 

 
238.2

Payments of assumed NYX debt and other acquisitions debt
 

 

 
(1.9
)
 
(288.2
)
 

 
(290.1
)
Payments of debt issuance and deferred financing costs
 

 
(38.5
)
 

 

 

 
(38.5
)
Payments on license obligations
 
(42.9
)
 

 
(2.0
)
 

 

 
(44.9
)
Net redemptions of common stock under stock-based compensation plans and other
 
(18.4
)
 

 
(2.5
)
 

 

 
(20.9
)
Other, principally change in intercompany financing activities
 
(341.7
)
 

 
(61.5
)
 
562.5

 
(159.3
)
 

Net cash (used in) provided by financing activities
 
(403.0
)
 
207.2

 
(67.9
)
 
266.8

 
(159.3
)
 
(156.2
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
 

 

 

 
(5.9
)
 

 
(5.9
)
(Decrease) increase in cash, cash equivalents and restricted cash
 
(659.1
)
 
1.1

 
(0.1
)
 
42.1

 
1.9

 
(614.1
)
Cash, cash equivalents, and restricted cash, beginning of period
 
732.6

 
0.6

 
43.9

 
60.2

 
(3.2
)
 
834.1

Cash, cash equivalents and restricted cash, end of period
 
$
73.5

 
$
1.7

 
$
43.8

 
$
102.3

 
$
(1.3
)
 
$
220.0

 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes, the 2025 Secured Notes, which were issued in October 2017, and the 2026 Secured Euro Notes and 2026 Unsecured Euro Notes, which were issued in February 2018.


SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Year Ended December 31, 2017


SGC (Parent)

SGI (Issuer1)

Guarantor
Subsidiaries

Non-
Guarantor
Subsidiaries

Eliminating
Entries

Consolidated
Net cash (used in) provided by operating activities
 
$
(40.7
)
 
$
(300.0
)
 
$
567.3

 
$
282.6

 
$
(2.1
)
 
$
507.1

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
  Capital expenditures
 
(53.3
)
 
(31.0
)
 
(128.8
)
 
(80.6
)
 

 
(293.7
)
Acquisitions of businesses, net of cash acquired
 

 

 
(26.3
)
 
(31.4
)
 

 
(57.7
)
Acquisitions and additions to equity method investments
 

 

 

 
(107.3
)
 

 
(107.3
)
Distributions of capital on equity investments
 

 

 

 
34.1

 

 
34.1

Changes in other assets and liabilities and other
 

 

 
7.5

 
2.5

 

 
10.0

Other, principally change in intercompany investing activities
 

 
(569.1
)
 

 
(120.1
)
 
689.2

 

Net cash (used in) provided by investing activities
 
(53.3
)
 
(600.1
)
 
(147.6
)
 
(302.8
)
 
689.2

 
(414.6
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Net (payments) proceeds of long-term debt including senior notes and term loans
 
(250.0
)
 
957.7

 

 
(6.7
)
 

 
701.0

Payments of debt issuance and deferred financing costs
 

 
(58.7
)
 

 

 

 
(58.7
)
  Payments on license obligations
 
(47.5
)
 

 
(5.1
)
 

 

 
(52.6
)
Net redemptions of common stock under stock-based compensation plans and other
 
(8.5
)
 

 
(1.0
)
 

 

 
(9.5
)
Other, principally change in intercompany financing activities
 
1,099.9

 

 
(410.7
)
 

 
(689.2
)
 

Net cash provided by (used in) financing activities
 
793.9

 
899.0

 
(416.8
)
 
(6.7
)
 
(689.2
)
 
580.2

Effect of exchange rate changes on cash, cash equivalents and restricted cash
 

 

 

 
4.5

 

 
4.5

Increase (decrease) in cash, cash equivalents and restricted cash
 
699.9

 
(1.1
)
 
2.9

 
(22.4
)
 
(2.1
)
 
677.2

Cash, cash equivalents, and restricted cash, beginning of period
 
32.7

 
1.7

 
41.0

 
82.6

 
(1.1
)
 
156.9

Cash, cash equivalents and restricted cash, end of period
 
$
732.6

 
$
0.6

 
$
43.9

 
$
60.2

 
$
(3.2
)
 
$
834.1

 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, the Unsecured Notes and the 2025 Secured Notes, which were issued in October 2017.

SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES
SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
Year Ended December 31, 2016
 
 
SGC (Parent1)
 
SGI (Issuer2)
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
 
$
(90.4
)
 
$
(259.8
)
 
$
535.0

 
$
235.3

 
$
(1.1
)
 
$
419.0

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 
(39.1
)
 
(22.8
)
 
(149.5
)
 
(61.5
)
 

 
(272.9
)
Distribution of capital on equity investments
 

 

 

 
25.3

 

 
25.3

Changes in other assets and liabilities and other
 

 
(1.2
)
 
16.8

 
4.0

 

 
19.6

Other, principally change in intercompany investing activities
 

 
418.4

 

 
(194.5
)
 
(223.9
)
 

Net cash (used in) provided by investing activities
 
(39.1
)
 
394.4

 
(132.7
)
 
(226.7
)
 
(223.9
)
 
(228.0
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
 
Net payments on long-term debt
 

 
(132.9
)
 

 
(6.8
)
 

 
(139.7
)
Payments on license obligations
 
(38.0
)
 

 
(12.2
)
 

 

 
(50.2
)
Net (redemptions) issuances of common stock under stock-based compensation plans and other
 
(6.1
)
 

 

 

 

 
(6.1
)
Other, principally change in intercompany financing activities
 
163.1

 

 
(387.0
)
 

 
223.9

 

Net cash provided by (used in) financing activities
 
119.0

 
(132.9
)
 
(399.2
)
 
(6.8
)
 
223.9

 
(196.0
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
 

 

 

 
(4.9
)
 

 
(4.9
)
Increase (decrease) in cash, cash equivalents and restricted cash
 
(10.5
)
 
1.7

 
3.1

 
(3.1
)
 
(1.1
)
 
(9.9
)
Cash, cash equivalents, and restricted cash, beginning of period
 
43.2

 

 
37.9

 
85.7

 

 
166.8

Cash, cash equivalents and restricted cash, end of period
 
$
32.7

 
$
1.7

 
$
41.0

 
$
82.6

 
$
(1.1
)
 
$
156.9

 
 
 
 
 
 
 
 
 
 
 
 
 
(1) Issuer of obligations under the 2018 Notes, which were redeemed on March 17, 2017.
(2) Issuer of obligations under the 2020 Notes, the 2021 Notes, the 2022 Secured Notes, which were redeemed in March 2018, and the Unsecured Notes.